BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Johnson and Johnson
Colorcon
Mallinckrodt
Dow
Baxter
Express Scripts
US Department of Justice
UBS
Farmers Insurance

Generated: January 17, 2018

DrugPatentWatch Database Preview

TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Travasol 4.25% In Dextrose 20% In Plastic Container patents expire, and what generic alternatives are available?

Travasol 4.25% In Dextrose 20% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in two NDAs.

The generic ingredient in TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER is amino acids; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride. There are three hundred and forty-one drug master file entries for this compound. Additional details are available on the amino acids; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride profile page.
Summary for TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
Drug patent expirations by year for TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER

US Patents and Regulatory Information for TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare TRAVASOL 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER amino acids; dextrose INJECTABLE;INJECTION 019520-009 Sep 23, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER amino acids; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride INJECTABLE;INJECTION 020147-009 Oct 23, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Moodys
Citi
Johnson and Johnson
Cerilliant
Harvard Business School
Mallinckrodt
Cipla
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot